#1
|
|||
|
|||
Ñèíäðîì ïåðñèñòåíöèè òðîôîáëàñòà
Ñèíäðîì ïåðñèñòåíöèè òðîôîáëàñòà. Óâàæàåìûå êîëëåãè, ó êîãî åñòü èíôîðìàöèÿ ïî äàííîé ïðîáëåìå? Çàðàíåå áëàãîäàðåí.
|
#2
|
|||
|
|||
Ñòðóêòóèðîâàííîé èíôîðìàöèåé ïî äàííîìó âîïðîñó íå âëàäåþ, íî ïî òåìå õî÷åòñÿ óçíàòü ìíåíèå êîëëåã î âåäåíèè ïîñëåðîäîâîãî ïåðèîäà ó ðîäèëüíèö ñ òÿæ¸ëûì ãåñòîçîì. Ñóùåñòâóåò ìíåíèå , ÷òî ïðè ñòîéêîé ïîñëåðîäîâîé ïðîòåèíóðèè öåëåñîîáðàçíî ïðîâîäèòü âûñêàáëèâàíèå ìàòêè ñ öåëüþ óäàëåíèÿ äåöèäóàëüíîé òêàíè, äàæå åñëè ïî óçè ìàòêà ïóñòàÿ.
|
#3
|
|||
|
|||
Ïðèâåäèòå ññûëêè íà ìíåíèå î íåîáõîäèìîñòè ÐÄÂ ïîñëå ðîäîâ
|
#4
|
|||
|
|||
Öåðâèêàëüíûé êàíàë ìîæíî íå âûñêàáëèâàòü) Ëè÷íî íàáëþäàë èñ÷åçíîâåíèå ïðîòåèíóðèè íà 6 - å ñóòêè ïîñëå ðîäîâ , íà âòîðîé äåíü ïîñëå ïðîâåäåíèÿ âûñêàáëèâàíèÿ. Ñîñêîáà ïðàêòè÷åñêè íå áûëî , ãèñòîëîãè äàëè ìèîìåòðèé ñ ëèìôîöèòàðíîé èíôèëüòðàöèåé è áîëüøå íè÷åãî , äî âûñêàáëèâàíèÿ áåëîê çàøêàëèâàë äî 1.5 ã â ðàçîâîé ïîðöèè ìî÷è. ß áû ñàì ñ óäîâîëüñòâèåì ïðîø¸ë áû ïî ññûëêàì , ÷òîáû êðîìå ýìïèðè÷åñêèõ íàáëþäåíèé èìåòü â êà÷åñòâå îáîñíîâàíèÿ ïîäîáíûõ äåéñòâèé ÷òî òî åù¸.
|
#5
|
||||
|
||||
Âðåìÿ ëó÷øèé ëåêàðü: èç 205 æåíùèí ñ ïðåýêëàìïñèåé è ïðîòåèíóðèåé áîëåå 0.3 ã/ë ê 3 ìåñÿöàì îñòàëîñü âñåãî 28-29 èëè äðóãèìè ñëîâàìè ïðåýêëàìïòè÷åñêàÿ ïðîòåèíóðèÿ ó áåðåìåííûõ èñ÷åçàåò ñî ñêîðîñòüþ 1% â äåíü. Âîò åñëè Âû ñìîæåòå ïîêàçàòü, ÷òî âûñêàáëèâàíèå óñêîðÿåò ýòîò ïðîöåññ íàïðèìåð â 3-5 ðàç, òî òîãäà ìîæíî áóäåò óòâåðæäàòü, ÷òî äàííàÿ ïðîöåäóðà ñïîñîáñòâóåò áîëåå ñêîðåéøåìó èñ÷åçíîâåíèþ ïðîòåèíóðèè, à òàê ìîãëî áûòü ïðîñòî ñîâïàäåíèå...
Obstet Gynecol. 2009 Dec;114(6):1307-14. Resolution of hypertension and proteinuria after preeclampsia. Berks D, Steegers EA, Molas M, Visser W. SourceDepartment of Obstetrics and Gynecology, Division of Obstetric and Prenatal Medicine, Erasmus MC Medical Centre, Rotterdam, The Netherlands. Abstract OBJECTIVE: To estimate the time required for hypertension and proteinuria to resolve after preeclampsia, and to estimate how this time to resolution correlates with the levels of blood pressure and proteinuria during preeclampsia and prolonging pregnancy after the development of preeclampsia. METHODS: This is a historic prospective cohort study of 205 preeclamptic women who were admitted between 1990 and 1992 at the Erasmus MC Medical Centre, Rotterdam, The Netherlands. Data were collected at 1.5, 3, 6, 12, 18, and 24 months after delivery. Hypertension was defined as a blood pressure 140/90 mm Hg or higher or use of antihypertensive drugs. Proteinuria was defined as 0.3 g/d or more. Resolution of hypertension and proteinuria were analyzed with the Turnbull extension to the Kaplan-Meier procedure. Correlations were calculated with an accelerated failure time model. RESULTS: At 3 months postpartum, 39% of women still had hypertension, which decreased to 18% at 2 years postpartum. Resolution time increased by 60% (P<.001) for every 10-mm Hg increase in maximal systolic blood pressure, 40% (P=.044) for every 10-mm Hg increase in maximal diastolic blood pressure, and 3.6% (P=.001) for every 1-day increase in the diagnosis-to-delivery interval. At 3 months postpartum, 14% still had proteinuria, which decreased to 2% at 2 years postpartum. Resolution time increased by 16% (P=.001) for every 1-g/d increase in maximal proteinuria. Gestational age at onset of preeclampsia was not correlated with resolution time of hypertension and proteinuria. CONCLUSION: The severity of preeclampsia and the time interval between diagnosis and delivery are associated with postpartum time to resolution of hypertension and proteinuria. After preeclampsia, it can take up to 2 years for hypertension and proteinuria to resolve. Therefore, the authors suggest that further invasive diagnostic tests for underlying renal disease may be postponed until 2 years postpartum.
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#6
|
|||
|
|||
Èíòåðåñíàÿ èíôîðìàöèÿ,îçíàêîìèëñÿ, íàñêîëüêî ìíå ïîçâîëÿåò ìîé ïëîõîé àíãëèéñêèé) , òî åñòü â òå÷åíèè ïðåâûõ äâóõ ëåò ïîâîäà äëÿ áåñïîêîéñòâà íåò è âñ¸ ïîñòåïåííî âåðí¸òñÿ â íîðìó ) À êàê æå ïðèñòóïû ýêëàìïñèè â ïîçäíåì ïîñëåðîäîâîì ïåðèîäå ?
|
#7
|
||||
|
||||
Íàñêîëüêî ïîíèìàþ ïîñëåðîäîâàÿ ýêëàìïñèÿ íàñòîëüêî ðåäêà, ÷òî ñðåäè ïóáëèêàöèé â îñíîâíîì èäåò îïèñàíèå îäíîãî-äâóõ ñëó÷àåâ, íåäàâíèé îáçîð çà 8 ëåò â äâóõ ãîðîäñêèõ ãîñïèòàëÿõ Äåíâåðà, Êîëîðàäî, ÑØÀ îáíàðóæèë âñåãî 22 ñëó÷àÿ (ìåíåå 1.5 (!!!) ñëó÷àÿ â ãîä íà áîëüíèöó), èç íèõ ó ïîëîâèíû îòñóòñòâîâàëè ïðèçíàêè àíòå/ïåðèíàòàëüíîé ïðå/ýêëàìïñèè, áîëüøèíñòâî ñëó÷àåâ â òå÷åíèå 3-10 (ñðåäíå 5) äíåé ïîñëå ðîäîâ:
RESULTS: Of the 22 women, over half (55%) had not been diagnosed with preeclampsia in the ante- or peripartum period. Common prodromal symptoms and signs in the postpartum presentation included headache, visual changes, hypertension, edema, proteinuria, elevated uric acid, and elevated liver function tests. All 4 patients who seized had prodromal symptoms. Women presented from 3 to 10 days postpartum (median: 5 days). Only 10 women were primiparas. Nineteen women presented with diastolic blood pressures > 90 mm, and only 3 of these had diastolic blood pressures of 110 mm Hg or greater. CONCLUSIONS: Postpartum preeclampsia/eclampsia often presents to the ED without a history of preeclampsia during the pregnancy. Further, not all women with this diagnosis who present to the ED in the postpartum period will have each of the "classic" features of this disease, including elevated blood pressure, edema, proteinuria, and hyperreflexia. This report is intended to inform emergency physicians of the presentation of preeclampsia/eclampsia in the postpartum period, including symptoms of headache, vision changes, elevated blood pressure, or seizure up to 4 weeks after delivery. --- J Emerg Med. 2011 Apr;40(4):380-4. Postpartum preeclampsia: emergency department presentation and management.
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#8
|
|||
|
|||
Íàâåðíî ðåäêà , íî âîò ñåé÷àñ âïîëíå êîíêðåòíàÿ ñèòóàöèÿ , êîãäà íà 11 - å ñóòêè ïîñëåðîäîâîãî ï- äà ñóòî÷íûé áåëîê 2.1 ã , â ðàçîâîé ïîðöèè ìî÷è ñåãîäíÿ óòðîì 1.2 ã , ïî ìîèì ïðåäñòàâëåíèÿì ñ òàêîé ïðîòåèíóðèåé " òðÿõîíóòü" ìîæåò â ëþáîé ìîìåíò, ÷òî äåëàòü äàëüøå íå ïîíÿòíî.
|
#9
|
||||
|
||||
ïîñëå 10 äíåé ðèñê ðàçâèòèÿ ïîñëåðîäîâîé åêëàìïñèè ñòðåìèòñÿ ê íóëþ, íè÷åãî äåëàòü íå íóæíî, òîëüêî íàáëþäàòü àìáóëàòîðíî, ñîãëàñíî ïóáëèêàöèè èç Ãîëëàíäèè...
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#10
|
|||
|
|||
Ñïàñèáî! Âû ìåíÿ óñïîêîèëè.
|